Drug-drug Interaction Study of SPH3127
Clinical trial NCT05359055 · COMPLETED
Trial details
- NCT number
- NCT05359055
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2022-01-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.